Skip to content

Application of a small molecule inhibitor screen approach

Dharmasiri U, Witek MA, Adams AA, Soper SA

Posted on November 23, 2024 by Courtney Roberts

Dharmasiri U, Witek MA, Adams AA, Soper SA. the peripheral bloodstream and getting the potential to spread into arteries iatrogenically, which can be an early part of the cascade of occasions resulting in metastasis.4 CTCs captured from a bloodstream test offer an accessible supply for recognition potentially, characterization, and monitoring Continue Reading

Posted In Reagents

Categories

  • Activator Protein-1
  • Adenosine A3 Receptors
  • Adenosine, Other
  • AMPA Receptors
  • Amylin Receptors
  • Amyloid Precursor Protein
  • Angiotensin AT2 Receptors
  • AT Receptors, Non-Selective
  • CaM Kinase Kinase
  • Carbohydrate Metabolism
  • Catechol O-methyltransferase
  • COMT
  • DNA, RNA and Protein Synthesis
  • Dopamine Transporters
  • Dopaminergic-Related
  • DPP-IV
  • Endopeptidase 24.15
  • Exocytosis
  • F-Type ATPase
  • FAK
  • GLP2 Receptors
  • H2 Receptors
  • H4 Receptors
  • I??B Kinase
  • I1 Receptors
  • Inositol Monophosphatase
  • Isomerases
  • Leukotriene and Related Receptors
  • mGlu Group I Receptors
  • Mre11-Rad50-Nbs1
  • MRN Exonuclease
  • Muscarinic (M5) Receptors
  • N-Methyl-D-Aspartate Receptors
  • Neuropeptide FF/AF Receptors
  • NO Donors / Precursors
  • Other Proteases
  • Other Reductases
  • PKA
  • Platelet Derived Growth Factor Receptors
  • Polyamine Synthase
  • Protease-Activated Receptors
  • PrP-Res
  • Reagents
  • Reductase, 5??-
  • Selectins
  • Serotonin (5-HT1) Receptors
  • Tau
  • trpml
  • Tryptophan Hydroxylase
  • Urokinase-type Plasminogen Activator

Recent Posts

  • In 2007, Racil et approach
  • These glycosylases excise a broken base producing an abasic site that is converted to a single nucleotide space by AP endonuclease
  • L
  • Yet , vaccines ought to be reformulated annually owing to the rapid virus-like antigenic progress (Plotkin tout autant que al
  • The final decade indicates that there is a previously unrecognized variability among BoNT molecules: the serotypes A, M, E, and F can be distinguished into more than forty five subtypes based on their alanine sequence, antibody binding and functional activity
Copyright All rights reserved. Theme: Flash Blog by Unitedtheme.